NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday a 64 percent dip in its second quarter revenues.

For the three months ended June 30, the Gaithersburg, Maryland-based microbial genetics testing and analysis firm reported $375,146 in revenues, down from $1.1 million for the same quarter a year ago.

OpGen's Q2 product sales rose to $319,171 from $272,538 in the year-ago period, while its laboratory services sales fell to $28,195 from $121,899. Meantime, revenues from collaborations fell to $27,780 from $677,780 year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Sponsored by

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.  

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.